Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Marion R Munk

25PUBLICATIONS
30CO-AUTHORS
Vision scienceOptical technologyNeurology and neuromuscular diseasesPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

Sort by Publication Date:
|Feb 28, 2026
Correction: One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.

Anne Tillmann, Richard Stillenmunkes, Justus G Garweg

|Jan 30, 2026
SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration.

Clare Bailey, Clemens Lange, Varun Chaudhary

|Jan 16, 2026
Infographic: SPECTRUM: study design of the global real-world study of aflibercept 8 mg in the treatment of neovascular age-related macular degeneration and diabetic macular edema.

Clare Bailey, Clemens Lange, Marion R Munk

|Jan 06, 2026
Distinguishing Inherited Retinal Disease From Age-Related Macular Degeneration: Clinical Red Flags, Diagnostic Strategy, and the Expanding Role of Genetic Testing.

Ditta Zobor, Marion R Munk

|Oct 17, 2025
One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.

Anne Tillmann, Richard Stillenmunkes, Justus G Garweg

|Oct 10, 2025
Evaluating the risk of recurrence in neovascular age-related macular degeneration using OCT-angiography at the time of treatment exit.

Damian Jaggi, Sina Marugg, Lieselotte E Berger

Pageof 5

Frequent Collaborators

3 joint publications

Meng Tian

3 joint publications

Marc D de Smet

2 joint publications

Enrico Peiretti

2 joint publications

Christoph Tappeiner

2 joint publications

Jay Chhablani

2 joint publications

Tobias Machewitz

2 joint publications

Francesco Pichi

2 joint publications

Clare Bailey

2 joint publications

Martin Zinkernagel

2 joint publications

Chantal Dysli

Frequent Collaborators

3 joint publications

Meng Tian

3 joint publications

Marc D de Smet

2 joint publications

Enrico Peiretti

2 joint publications

Christoph Tappeiner

Top Related Videos

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
05:14

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on : Aug 11, 2023

1.6K
See more related videos

Top Related Videos

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
05:14

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on : Aug 11, 2023

1.6K
See more related videos